The 36-month beta value for AQST is also noteworthy at 2.90. There are mixed opinions on the stock, with 3 analysts rating it as a
The stock of Aquestive Therapeutics Inc (NASDAQ: AQST) has decreased by -0.44 when compared to last closing price of 4.07.Despite this, the company has seen
Aquestive Therapeutics Inc (NASDAQ: AQST) has seen a rise in its stock price by 3.90 in relation to its previous close of 4.10. However, the
The stock has a 36-month beta value of 2.85. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 1 as
Aquestive Therapeutics Inc (NASDAQ: AQST) has experienced a decline in its stock price by -6.62 compared to its previous closing price of 4.38. However, the
© 2024, Fueled by Smart TechOne
